Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on the development and commercialisation of innovative medicines for rare neuromuscular neuromuscular and pulmonary diseases with high unmet medical need, has announced an equity financing of CHF 20
Tags :Dieter Gericke
On Holding, a Swiss-based athletic shoe and performance sportswear company, has completed its initial public offering (IPO) on the NYSE, consisting of an offering of 31,100,000 Class A ordinary shares, of which 25,442,391 were offered by On
Homburger acted as Swiss counsel to Sophia Genetics on the initial listing of its shares on the Nasdaq Stock Market (ticker: SOPH). Sophia Genetics is a healthcare technology company dedicated to establishing the practice of
Molecular Partners, a clinical-stage biotech company, announced the pricing of its Initial Public Offering of 3,000,000 American Depositary Shares (ADS) in the United States at a public offering price of USD 21.25 per ADS, for total gross
Homburger advised Santhera Pharmaceuticals Holding on the settlement of its first exchange offer for a convertible bond in Switzerland. Holders of current Santhera CHF 60 Unsecured Convertible Bonds due in 2022 have received new CHF 30,270,375 Senior Unsecured
Homburger acted as Swiss counsel to Picanol in connection with the transaction. The team comprised partner Dieter Gericke (pictured) and associate Marc Hanslin (both Corporate / M&A). Stibbe BV/SRL (Jan Peeters) acted as Belgian
Homburger acted as legal counsel to the managers on this transaction with respect to all aspects of Swiss law. The team comprised partner Dieter Gericke and associate Lorenzo Togni (both Corporate / M&A, Capital Markets).
Homburger advised Byerley’s shareholders on the transaction. The team comprised partner Dieter Gericke (pictured) and associate Nicola Togni (both Corporate / M&A).
The law firm advised in connection with a collaboration with Novartis to develop DARPin® therapies designed for potential use against Covid-19. The team was led by partner Dieter Gericke (Corporate/ M&A, Capital Markets -
The team is led by partner Dieter Gericke (Corporate/M&A) and includes lead associate Daniel Häusermann (Corporate/ M&A), partners Reto Heuberger (Tax) and Benjamin Leisinger (Banking and Finance), as well as associates
